284 related articles for article (PubMed ID: 19459987)
21. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.
Pilishvili T; Lexau C; Farley MM; Hadler J; Harrison LH; Bennett NM; Reingold A; Thomas A; Schaffner W; Craig AS; Smith PJ; Beall BW; Whitney CG; Moore MR;
J Infect Dis; 2010 Jan; 201(1):32-41. PubMed ID: 19947881
[TBL] [Abstract][Full Text] [Related]
22. Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades.
Harboe ZB; Benfield TL; Valentiner-Branth P; Hjuler T; Lambertsen L; Kaltoft M; Krogfelt K; Slotved HC; Christensen JJ; Konradsen HB
Clin Infect Dis; 2010 Feb; 50(3):329-37. PubMed ID: 20047478
[TBL] [Abstract][Full Text] [Related]
23. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.
Pai R; Moore MR; Pilishvili T; Gertz RE; Whitney CG; Beall B;
J Infect Dis; 2005 Dec; 192(11):1988-95. PubMed ID: 16267772
[TBL] [Abstract][Full Text] [Related]
24. Invasive pneumococcal disease among HIV-positive individuals, 2000-2009.
Yin Z; Rice BD; Waight P; Miller E; George R; Brown AE; Smith RD; Slack M; Delpech VC
AIDS; 2012 Jan; 26(1):87-94. PubMed ID: 22008657
[TBL] [Abstract][Full Text] [Related]
25. Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):253-7. PubMed ID: 20224541
[TBL] [Abstract][Full Text] [Related]
26. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.
Black S; France EK; Isaacman D; Bracken L; Lewis E; Hansen J; Fireman B; Austrian R; Graepel J; Gray S; Klein NP
Pediatr Infect Dis J; 2007 Sep; 26(9):771-7. PubMed ID: 17721369
[TBL] [Abstract][Full Text] [Related]
27. The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes.
Lehmann D; Willis J; Moore HC; Giele C; Murphy D; Keil AD; Harrison C; Bayley K; Watson M; Richmond P
Clin Infect Dis; 2010 Jun; 50(11):1477-86. PubMed ID: 20420501
[TBL] [Abstract][Full Text] [Related]
28. Herd immunity and pneumococcal conjugate vaccine: a quantitative model.
Haber M; Barskey A; Baughman W; Barker L; Whitney CG; Shaw KM; Orenstein W; Stephens DS
Vaccine; 2007 Jul; 25(29):5390-8. PubMed ID: 17583392
[TBL] [Abstract][Full Text] [Related]
29. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.
Klugman KP; Madhi SA; Huebner RE; Kohberger R; Mbelle N; Pierce N;
N Engl J Med; 2003 Oct; 349(14):1341-8. PubMed ID: 14523142
[TBL] [Abstract][Full Text] [Related]
30. Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990-2003.
Barry PM; Zetola N; Keruly JC; Moore RD; Gebo KA; Lucas GM
AIDS; 2006 Feb; 20(3):437-44. PubMed ID: 16439878
[TBL] [Abstract][Full Text] [Related]
31. The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children.
Thanee C; Pancharoen C; Likitnukul S; Luangwedchakarn V; Umrod P; Phasomsap C; Apornpong T; Chuanchareon T; Butterworth O; Puthanakit T
Vaccine; 2011 Aug; 29(35):5886-91. PubMed ID: 21729732
[TBL] [Abstract][Full Text] [Related]
32. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.
Albrich WC; Baughman W; Schmotzer B; Farley MM
Clin Infect Dis; 2007 Jun; 44(12):1569-76. PubMed ID: 17516400
[TBL] [Abstract][Full Text] [Related]
33. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.
Shouval DS; Greenberg D; Givon-Lavi N; Porat N; Dagan R
Pediatr Infect Dis J; 2009 Apr; 28(4):277-82. PubMed ID: 19258924
[TBL] [Abstract][Full Text] [Related]
34. Clinical presentation of invasive pneumococcal disease in Spain in the era of heptavalent conjugate vaccine.
de Sevilla MF; García-García JJ; Esteva C; Moraga F; Hernández S; Selva L; Coll F; Ciruela P; Planes AM; Codina G; Salleras L; Jordan I; Domínguez A; Muñoz-Almagro C
Pediatr Infect Dis J; 2012 Feb; 31(2):124-8. PubMed ID: 22173137
[TBL] [Abstract][Full Text] [Related]
35. Serotype replacement in perspective.
Dagan R
Vaccine; 2009 Aug; 27 Suppl 3():C22-4. PubMed ID: 19545935
[TBL] [Abstract][Full Text] [Related]
36. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
Dagan R
Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365
[TBL] [Abstract][Full Text] [Related]
37. Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme.
Ingels H; Rasmussen J; Andersen PH; Harboe ZB; Glismann S; Konradsen H; Hoffmann S; Valentiner-Branth P; Lambertsen L;
Vaccine; 2012 Jun; 30(26):3944-50. PubMed ID: 22504662
[TBL] [Abstract][Full Text] [Related]
38. [Epidemiology of invasive pneumococcal disease in children in Gipuzkoa (Spain) from 1981 to 2001].
Iglesias Sánchez L; Pérez-Yarza EG; García-Arenzana JM; Valiente Méndez A; Pérez-Trallero E
An Esp Pediatr; 2002 Nov; 57(5):401-7. PubMed ID: 12467542
[TBL] [Abstract][Full Text] [Related]
39. Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines.
Hampton LM; Farley MM; Schaffner W; Thomas A; Reingold A; Harrison LH; Lynfield R; Bennett NM; Petit S; Gershman K; Baumbach J; Beall B; Jorgensen J; Glennen A; Zell ER; Moore M
J Infect Dis; 2012 Feb; 205(3):401-11. PubMed ID: 22158567
[TBL] [Abstract][Full Text] [Related]
40. Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation.
Ispahani P; Slack RC; Donald FE; Weston VC; Rutter N
Arch Dis Child; 2004 Aug; 89(8):757-62. PubMed ID: 15269078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
